Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2009
10/25/2009CA2629979A1 Novel resveratrol compositions
10/24/2009CA2683209A1 Pyrimidinones as casein kinase ii (ck2) modulators
10/22/2009WO2009129548A1 Antioxidant inflammation modulators: c-17 homologated oleanolic acid derivatives
10/22/2009WO2009129546A1 Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17
10/22/2009WO2009129545A1 Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the c-ring
10/22/2009WO2009129532A1 Compounds for lysosomal modulation and methods of use
10/22/2009WO2009129531A2 Bupivacaine formulation in a polyorthoester carrier
10/22/2009WO2009129527A2 Baclofen formulation in a polyorthoester carrier
10/22/2009WO2009129525A2 Antifungal and anti-cariogenic cellobio-oligosaccharides produced by dextransucrase
10/22/2009WO2009129519A2 Benzodiazepine formulation in a polyorthoester carrier
10/22/2009WO2009129511A2 Fluocinolone formulations in a biodegradable polymer carrier
10/22/2009WO2009129510A2 Sulindac formulations in a biodegradable material
10/22/2009WO2009129509A2 Methods and compositions for treating post-operative pain comprising a local anesthetic
10/22/2009WO2009129508A1 Soluble epoxide hydrolase inhibitors
10/22/2009WO2009129501A1 Use of soluble epoxide hydrolase inhibitors in the treatment of smooth muscle disorders
10/22/2009WO2009129497A2 Methods and compositions for treating and identifying compounds to treat age-related macular degeneration
10/22/2009WO2009129494A2 Alpha and beta adrenergic receptor agonists for treatment of pain and/or inflammation
10/22/2009WO2009129491A2 Beta adrenergic receptor agonists for treatment of pain and/or inflammation
10/22/2009WO2009129465A2 Compositions and methods for inhibiting expression of xbp-1 gene
10/22/2009WO2009129464A2 Method for treating acute pain with a formulated drug depot in combination with a liquid formulation
10/22/2009WO2009129460A2 Clonidine formulations in a biodegradable polymer carrier
10/22/2009WO2009129456A2 Alpha adrenergic receptor agonists for treatment of inflammatory diseases
10/22/2009WO2009129453A2 Clonidine formulation in a polyorthoester carrier
10/22/2009WO2009129437A2 Methods and compositions for treating post-operative pain comprising clonidine
10/22/2009WO2009129433A2 Alpha adrenergic receptor agonists for treatment of degenerative disc disease
10/22/2009WO2009129432A2 Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
10/22/2009WO2009129428A2 Methods for treating post-operative effects such as spasticity and shivering with clonidine
10/22/2009WO2009129408A2 Compositions and methods for treating pathologic angiogenesis and vascular permeability
10/22/2009WO2009129401A1 Kinase inhibitors
10/22/2009WO2009129372A1 Compounds and methods for treating estrogen receptor-related diseases
10/22/2009WO2009129371A1 Cathepsin c inhibitors
10/22/2009WO2009129370A1 Cathepsin c inhibitors
10/22/2009WO2009129365A1 Cathepsin c inhibitors
10/22/2009WO2009129361A2 Macrocyclic compounds and methods of making and using thereof
10/22/2009WO2009129336A2 Penetrating carrier, antifungal composition using the same and method for treatment of dermatophyte infections
10/22/2009WO2009129321A1 Compounds and methods for activated therapy
10/22/2009WO2009129317A1 An inhibitor of anti-apoptotic proteins
10/22/2009WO2009129305A2 Prodrugs of neuraminidase inhibitors
10/22/2009WO2009129301A2 Oral pharmaceutical compositions in a molecular solid dispersion
10/22/2009WO2009129297A1 Semi-solid oral pharmaceutical compositions
10/22/2009WO2009129260A2 Calycosin and analogs thereof for the treatment of estrogen receptor beta-mediated diseases
10/22/2009WO2009129259A2 Polymorphs of 5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-n-(1-methylpiperidin-4-yl)-9h-pyrido[2,3-b]indole-7-carboxamide and methods of use therefor
10/22/2009WO2009129246A2 Compositions and methods for preparing and using same
10/22/2009WO2009129227A1 Stimulation of an immune response by enantiomers of cationic lipids
10/22/2009WO2009129225A1 Compounds and methods for altering bone growth
10/22/2009WO2009129211A1 Inhibitors of phosphatidylinositol 3-kinase
10/22/2009WO2009129208A2 Compositions and methods of inducing endoplasmic reticulum stress reponse
10/22/2009WO2009129191A1 Polymorphs of hydrochloride salt o5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-n-(1-methylpiperidin-4-yl)-9h-pyrido[2,3-b] indole-7-carboxamideand methods of use therefor
10/22/2009WO2009129181A1 Propanediol-dicarbamate derivatives
10/22/2009WO2009129164A1 Pharmaceutical combinations of tfpi-fragments and an antibiotic
10/22/2009WO2009129155A2 Dexamethasone formulations in a biodegradable material
10/22/2009WO2009129149A2 Drug depots having different release profiles for reducing, preventing or treating pain and inflammation
10/22/2009WO2009129148A2 Methods and compositions for treating intervertebral disc herniations
10/22/2009WO2009129147A2 Analgesic and anti-inflammatory compositions and methods for reducing, preventing or treating pain and inflammation
10/22/2009WO2009129145A2 Sulfasalazine formulations in a biodegradable polymer carrier
10/22/2009WO2009129120A2 Nucleoside derivatives for treatment of caliciviridae infections, including norovirus infections
10/22/2009WO2009129109A1 Hepatitis c virus inhibitors
10/22/2009WO2009129097A1 Nitrated hydrocarbons, derivatives, and processes for their manufacture
10/22/2009WO2009129094A2 Compositions containing antiviral compounds and methods of using the same
10/22/2009WO2009129036A1 Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment
10/22/2009WO2009128974A1 Kappa opioid receptor ligands
10/22/2009WO2009128964A2 Ensemble-based virtual screening reveals novel antiviral compounds for avian influenza neuraminidase
10/22/2009WO2009128955A1 Treatment of inflammatory bowel disease with 6-mercaptopurine
10/22/2009WO2009128947A1 Piperazine derivatives
10/22/2009WO2009128934A1 Topical lfa-1 antagonists for use in localized treatment of immune related disorders
10/22/2009WO2009128933A1 Aerosolized lfa-1 antagonists for use in localized treatment of immune related disorders
10/22/2009WO2009128919A1 Deuterium bearing analogs of anastrozole as aromatase inhibitors for the treatment of breast cancer
10/22/2009WO2009128918A1 Combination therapy using a soluble hyaluronidase and a bisphosphonate
10/22/2009WO2009128917A2 Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions
10/22/2009WO2009128805A1 On01910. na enhances chemotherapeutic agent activity in drug-resistant tumors
10/22/2009WO2009128795A1 Iron and zinc based pharmaceutical formulation for iron deficiency treatment
10/22/2009WO2009128692A1 Method and pharmaceutical composition for obtaining the plasmatic progesterone levels required for different therapeutic indications
10/22/2009WO2009128558A1 Activator for peroxisome proliferator-activated receptor
10/22/2009WO2009128547A1 Gene expression inhibitor selective for matrix metalloproteinase-9 gene
10/22/2009WO2009128543A1 Process for producing silica-containing tablet, tablet, and composite particle for tablet
10/22/2009WO2009128537A1 Heterocyclic compound
10/22/2009WO2009128523A1 Immunostimulating agent
10/22/2009WO2009128521A1 Cysteine protease inhibitor
10/22/2009WO2009128520A1 Heterocyclic compound having inhibitory activity on p13k
10/22/2009WO2009128481A1 Nitrogenated 5-membered heterocyclic compound
10/22/2009WO2009128479A1 Imidazoline derivative
10/22/2009WO2009128421A1 Hemifumarate of a pyrazole derivative
10/22/2009WO2009128395A1 Bone formation promoter comprising 2-aminophenol or derivative thereof as active ingredient
10/22/2009WO2009128383A1 3-PHENYLPYRAZOLO[5,1-b]THIAZOLE COMPOUND
10/22/2009WO2009128360A1 Therapeutic agent for diabetes
10/22/2009WO2009128262A1 Quinolone derivative and use thereof
10/22/2009WO2009128085A1 Process for the preparation of cross-linked polyallylamine polymer
10/22/2009WO2009128058A1 Psycho-pharmaceuticals
10/22/2009WO2009128057A2 Psycho-pharmaceuticals
10/22/2009WO2009128050A2 Pharmaceutical composition and its use
10/22/2009WO2009128019A1 Tricyclic antibiotics
10/22/2009WO2009127996A1 Novel crystalline form of lamivudine
10/22/2009WO2009127949A1 4- [3- (aryloxy) benzylidene] -3-methyl piperidine aryl carboxamide compounds useful as faah inhibitors
10/22/2009WO2009127948A1 4- [3- (aryloxy) benzylidene] -3-methyl piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors
10/22/2009WO2009127946A1 4-benzylidene-3-methylpiperidine aryl carboxamide compounds useful as faah inhibitors
10/22/2009WO2009127944A1 Ether benzylidene piperidine aryl carboxamide compounds useful as faah inhibitors
10/22/2009WO2009127943A1 Ether benzylidene piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors
10/22/2009WO2009127924A1 Compositions and devices for antisepsis and anticoagulation
10/22/2009WO2009127922A2 Pharmaceutical formulation for treating cardiovascular disease
10/22/2009WO2009127881A1 Anti-areg/hb-egf antibodies and treatment
1 ... 2526 2527 2528 2529 2530 2531 2532 2533 2534 2535 2536 2537 2538 2539 2540 2541 2542 2543 2544 2545 2546 ... 7860